RESIDUAL DISEASE
Clinical trials for RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug combo targets tough breast cancer after surgery
Disease control OngoingThis early-phase study tests the drug niraparib given together with radiation therapy after surgery for triple negative breast cancer. It includes 21 patients who still had cancer cells after chemotherapy. The main goal is to find the safest dose of niraparib and see if the combi…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Can vaccines keep breast cancer away? new study tests two options
Prevention OngoingThis study tests two vaccines designed to prevent breast cancer from returning in people who have already been treated for HER2-positive breast cancer. About 119 participants who had chemotherapy and surgery but still had cancer cells left will receive one of the vaccines. The go…
Matched conditions: RESIDUAL DISEASE
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Prevention
Last updated May 11, 2026 20:38 UTC